Intra-abdominal sepsis is usually a complication of intraabdominal inf
ection, secondary to gastrointestinal tract perforation or loss of int
estinal barrier integrity, Consecutive spread of enteric bacteria and
(endo)toxins is followed by the release of inflammatory mediators (cyt
okines) causing a systemic inflammatory response, and eventually immun
oparalysis and (septic) multi-organ dysfunction. Eradication of the in
fection focus, together with appropriate antibiotic therapy and suppor
tive intensive care, are the cornerstones of treating abdominal sepsis
, Therapeutic strategies aimed at influencing the immune response have
been attempted but have not yet proved to be effective in controlled
clinical trials.